A year till Brexit, money still flowing into UK biotech

Whether positive or negative, the findings from reports on elements of the UK economy are frequently linked to UK’s imminent exit from the European Union in the current Brexit-obsessed media environment.

But a report showing that venture capital funding and follow-on financing in biotech are off to a solid start in 2018 suggests that the sector continues to flourish in the UK, as it did in 2017 and is fluorishing globally, regardless of Brexit or other political uncertainties.

"Biopharma offerings globally so far in 2018 are double 2017 levels. This bodes well for a cash-hungry, market-ready companies in the UK"